Aquatic Capital Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-66,339
Closed -$265K 1502
2025
Q4
$265K Sell
66,339
-92,633
-58% -$515K 0.01% 921
2025
Q3
$1.34M Buy
+158,972
New +$1.54M 0.03% 588
2025
Q1
Sell
-75,110
Closed -$845K 1355
2024
Q4
$845K Buy
+75,110
New +$1.32M 0.02% 599
2024
Q3
Sell
-72,200
Closed -$1.38M 1249
2024
Q2
$1.38M Buy
72,200
+35,800
+98% +$914K 0.05% 333
2024
Q1
$1.19M Buy
36,400
+24,500
+206% +$782K 0.04% 353
2023
Q4
$393K Buy
+11,900
New +$337K 0.01% 688
2023
Q3
Sell
-29,600
Closed -$897K 1363
2023
Q2
$897K Buy
29,600
+24,700
+504% +$799K 0.05% 327
2023
Q1
$159K Sell
4,900
-6,000
-55% -$190K 0.01% 642
2022
Q4
$306K Buy
+10,900
New +$312K 0.02% 641

Other funds holding EVH

Aquatic Capital Management's EVH Position: Q1 2026 in Review

Aquatic Capital Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 66,339 shares — an estimated $265K sold.

Aquatic Capital Management first reported a position in EVH in Q4 2022 and held it in 9 quarters. The position peaked at $1.38M in Q2 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Aquatic Capital Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 66,339 Evolent Health shares in Q1 2026, an estimated $265K.
  • Aquatic Capital Management first reported a position in Evolent Health in Q4 2022 and held it in 9 quarters.
  • Aquatic Capital Management's Evolent Health position peaked at $1.38M in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.